At consultation we will recommend the product that best fits your area, your tolerance for downtime and your schedule
Clinical studies show that GLP-1 receptor agonists produce meaningful weight loss across diverse populations, with the FDA approving semaglutide for weight management in adults with a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related health conditions
The core of Melanotan 1's mechanism is its interaction with the melanocortin 1 receptor (MC1R)
These could include: cost of medication access to medication side effects desire for a smaller amount of weight loss stigma around obesity medication weight management Experts interviewed by Healthline say they dont prescribe compounded GLP-1s at their clinics, but both acknowledge the ongoing challenges related to cost, insurance coverage, and access to these medications
Recently, an oral formulation of Wegovy and a new oral GLP-1, Foundayo (Lilly), were approved, which could increase adoption rates of these drugs even further
Are there any potential side effects of GLP-1 treatments